These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 523855)

  • 41. [Pharmacokinetic study of guanfacine in patients with renal insufficiency and in patients under chronic dialysis (author's transl)].
    Kiechel JR; Lavene D; Gurret M; Coustenoble J; Petrover M; Godin M; Fillastre JP
    Nephrologie; 1980; 1(2):73-81. PubMed ID: 7029332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of serum creatinine measurement error on dose adjustment in renal failure.
    Schneider V; Henschel V; Tadjalli-Mehr K; Mansmann U; Haefeli WE
    Clin Pharmacol Ther; 2003 Nov; 74(5):458-67. PubMed ID: 14586386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Vitamin A metabolism in dialysis patients--are dialysis patients poisoned by vitamin A? (author's transl)].
    Kawaguchi S; Maeda K; Yamamoto A; Kobayshi K
    Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1209-20. PubMed ID: 7193257
    [No Abstract]   [Full Text] [Related]  

  • 44. Reduced postheparin plasma diamine oxidase activity in patients with chronic renal failure.
    Stein J; Scheuermann EH; Yazdi R; Lembcke B; Caspary WF
    Z Gastroenterol; 1994 Apr; 32(4):236-9. PubMed ID: 8017098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)].
    Schmidt P; Korn A; Hitzenberger G; Zazgornik J; Kopsa H; Pils P
    Wien Med Wochenschr; 1980 Feb; 130(4):171-3. PubMed ID: 7376686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Folates and vitamin B12 in chronic renal failure. A prospective study in haemodialysis patients (author's transl)].
    Hernández Nieto L; Brito Barroso ML; García Pérez J; Maceira Cruz B; Gonález García C
    Sangre (Barc); 1980; 25(5B):665-75. PubMed ID: 7466550
    [No Abstract]   [Full Text] [Related]  

  • 48. Iron absorption and retention in chronic renal failure.
    Hawkins JB; Sammons HG; Smits BJ; Robinson BH
    Gut; 1969 Dec; 10(12):1054. PubMed ID: 5366267
    [No Abstract]   [Full Text] [Related]  

  • 49. [Diuretic therapy in moderate and advanced renal failure].
    Stein G
    Internist (Berl); 1992 Aug; 33 Suppl 1():S31-4. PubMed ID: 1428694
    [No Abstract]   [Full Text] [Related]  

  • 50. [Heparin dosage in chronic hemodialysis (author's transl)].
    Vogel GE; Hansen W; Goldmann FL; Kopp KF
    Med Klin; 1977 Oct; 72(40):1617-23. PubMed ID: 916946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of renal risk drugs in hospitalized patients with impaired renal function--an underestimated problem?
    Blix HS; Viktil KK; Moger TA; Reikvam A
    Nephrol Dial Transplant; 2006 Nov; 21(11):3164-71. PubMed ID: 16880181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Changes of guanidino compounds in chronic renal failure (author's transl)].
    Shitomoto M; Otsuji S
    Nihon Jinzo Gakkai Shi; 1979 Jan; 21(1):33-49. PubMed ID: 449116
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug pharmacokinetics in patients with renal failure.
    Franson TR; Sorensen ET
    IMJ Ill Med J; 1978 Feb; 153(2):111-6. PubMed ID: 24023
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug prescribing for patients in renal failure.
    Anderson RJ
    Hosp Pract (Off Ed); 1983 Feb; 18(2):145-9, 153-5, 157-60. PubMed ID: 6401675
    [No Abstract]   [Full Text] [Related]  

  • 56. The biotransformation of drugs in renal failure.
    Reidenberg MM
    Am J Med; 1977 Apr; 62(4):482-5. PubMed ID: 851117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Digitalis dosage in dialysed patients (author's transl)].
    Kakiuchi T; Tabata Y; Mabuchi H; Murao Y; Aoki T; Nakahashi H
    Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1173-82. PubMed ID: 7463851
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immune behaviour and immune supplemental therapy in chronic hemodialyzed patients (author's transl)].
    Fujita Y; Inoue S; Sato E; Takase S; Inoue H; Komaba K; Goto T; Miki S; Shimazaki K; Kanatsu K; Hirouchi H; Yamanishi J; Naito H; Horiguchi S; Honjo A; Nishioka M; Sakai R
    Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1427-41. PubMed ID: 7334723
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of maltitol or mannitol on gastrointestinal absorption of drugs (author's transl)].
    Niwa H; Hikichi N; Sakurai E; Ueda M; Fukuse G
    Yakugaku Zasshi; 1980 Nov; 100(11):1118-26. PubMed ID: 6782230
    [No Abstract]   [Full Text] [Related]  

  • 60. What are the important drug use errors in dialysis patients? Pharmacokinetic and pharmacodynamic principles.
    Dager WE
    Semin Dial; 2010; 23(5):466-9. PubMed ID: 21069914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.